We are live on ! Find out more
TXG icon

10x Genomics
TXG

92 hedge funds and large institutions have $1.13B invested in 10x Genomics in 2019 Q3 according to their latest regulatory filings, with 92 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

113.98% more ownership

Funds ownership: 0% → 113.98% (+114%)

Holders
92
Holders Change
+92
Holders Change %
–
% of All Funds
2.02%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.09%
New
92
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management II
California
+$378M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$152M
3
VMI
VHCP Management II
New York
+$98.9M
4
JCM
JS Capital Management
New York
+$92.8M
5
Wells Fargo
Wells Fargo
California
+$50.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NM
76
NWI Management
New York
$252K +$277K +5,000 New
RI
77
RTW Investments
New York
$252K +$277K +5,000 New
PMAM
78
Picton Mahoney Asset Management
Ontario, Canada
$251K +$277K +5,000 New
TRCT
79
Tower Research Capital (TRC)
New York
$250K +$274K +4,952 New
MCIM
80
Meadow Creek Investment Management
Georgia
$249K +$274K +4,944 New
BM
81
Brandywine Managers
Delaware
$217K +$238K +4,300 New
SG Americas Securities
82
SG Americas Securities
New York
$203K +$223K +4,029 New
CSS
83
Cubist Systematic Strategies
Connecticut
$59K +$65.1K +1,177 New
UBS Group
84
UBS Group
Switzerland
$52K +$57.4K +1,037 New
PAM
85
Panagora Asset Management
Massachusetts
$50K +$55.3K +1,000 New
WPA
86
West Paces Advisors
Georgia
$22.9K +$25.2K +455 New
Point72 Asset Management
87
Point72 Asset Management
Connecticut
$20K +$22.1K +400 New
VFA
88
Valeo Financial Advisors
Indiana
$13K +$13.8K +250 New
FIA
89
FNY Investment Advisers
New York
$10K +$11.1K +200 New
CCA
90
Catalyst Capital Advisors
New York
$7K +$7.75K +140 New
Bank of America
91
Bank of America
North Carolina
$4K +$4.15K +75 New
Royal Bank of Canada
92
Royal Bank of Canada
Ontario, Canada
$4K +$4.59K +83 New
1 2 3
4

TXG Hedge Fund Activity: Q3 2019 in Review

92 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q3 2019, worth a combined $1.13B.

Buyers outnumbered sellers: 92 funds opened new TXG positions and 0 closed out — a net gain of 92 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Foresite Capital Management II, opening a new position worth an estimated $378M.

  • 92 institutional investors held 10x Genomics (TXG) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $1.13B of 10x Genomics stock for Q3 2019.
  • 92 funds opened new 10x Genomics positions in Q3 2019 and 0 closed out, a net change of +92 holders.
  • The largest 10x Genomics buyer in Q3 2019 was Foresite Capital Management II, an estimated $378M added.

Based on aggregated 13F filings for Q3 2019.